EAM Investors’s Phibro Animal Health PAHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.65M Buy
84,106
+23,131
+38% +$1.1M 0.54% 63
2025
Q4
$2.28M Sell
60,975
-43,654
-42% -$1.77M 0.25% 158
2025
Q3
$4.17M Buy
+104,629
New +$3.46M 0.48% 104
2015
Q3
Sell
-30,709
Closed -$1.2M 322
2015
Q2
$1.2M Sell
30,709
-10,466
-25% -$361K 0.14% 279
2015
Q1
$1.46M Sell
41,175
-78,308
-66% -$2.52M 0.17% 231
2014
Q4
$3.77M Buy
+119,483
New +$3.3M 0.53% 39

Other funds holding PAHC

EAM Investors's PAHC Position: Q1 2026 in Review

EAM Investors increased its Phibro Animal Health (PAHC) stake by 38% in Q1 2026, buying an estimated $1.1M and bringing the position to 84,106 shares worth $4.65M. The position accounts for 0.54% of the portfolio, ranked #63.

EAM Investors first reported a position in PAHC in Q4 2014 and has held it in 6 quarters since. 257 funds tracked by Wall St. Rank hold PAHC as of Q1 2026.

  • EAM Investors held 84,106 shares of Phibro Animal Health worth $4.65M as of Q1 2026.
  • EAM Investors bought 23,131 Phibro Animal Health shares in Q1 2026, an estimated $1.1M.
  • Phibro Animal Health made up 0.54% of EAM Investors's portfolio in Q1 2026, its #63 holding.
  • EAM Investors first reported a position in Phibro Animal Health in Q4 2014 and has held it in 6 quarters since.
  • 257 funds tracked by Wall St. Rank held Phibro Animal Health as of Q1 2026.

Based on EAM Investors's 13F filing for Q1 2026, filed 13 May 2026.